Abstract |
The nociceptin receptor (NOP) and its ligand nociceptin/orphanin FQ (N/OFQ) have been shown to exert a modulatory effect on immune cells during sepsis. We evaluated the suitability of an experimental lipopolysaccharide (LPS)-induced sepsis model for studying changes in the nociceptin system. C57BL/6 mice BALB/c mice and Wistar rats were inoculated with different doses of LPS with or without a nociceptin receptor antagonist (UFP-101 or SB-612111). In C57BL/6 mice LPS 0.85 mg/kg injection produced no septic response, whereas 1.2mg/kg produced a profound response within 5h. In BALB/c mice, LPS 4 mg/kg produced no response, whereas 7 mg/kg resulted in a profound response within 24h. In Wistar rats LPS 15 mg/kg caused no septic response in 6/10 animals, whereas 25mg/kg resulted in marked lethargy before 24h. Splenic interleukin-1β mRNA in BALB/c mice, and serum TNF-α concentrations in Wistar rats increased after LPS injection in a dose-dependent manner, but were undetectable in control animals, indicating that LPS had stimulated an inflammatory reaction. IL-1β and TNF-α concentrations in LPS-treated animals were unaffected by administration of a NOP antagonist. Similarly NOP antagonists had no effect on survival or expression of mRNA for NOP or ppN/OFQ (the N/OFQ precursor) in a variety of tissues. In these animal models, the dose-response curve for LPS was too steep to allow use in survival studies and no changes in the N/OFQ system occurred within 24h. We conclude that LPS-inoculation in rodents is an unsuitable model for studying possible changes in the NOP-N/OFQ system in sepsis.
|
Authors | Roisin C Thomas, Michael F Bath, Cordula M Stover, David G Lambert, Jonathan P Thompson |
Journal | Peptides
(Peptides)
Vol. 61
Pg. 56-60
(Nov 2014)
ISSN: 1873-5169 [Electronic] United States |
PMID | 25161013
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier Inc. All rights reserved. |
Chemical References |
- (Nphe(1),Arg(14),Lys(15))N-OFQ NH(2)
- Cycloheptanes
- IL1B protein, mouse
- Interleukin-1beta
- Lipopolysaccharides
- Opioid Peptides
- Piperidines
- Receptors, Opioid
- Tumor Necrosis Factor-alpha
- cis-1-methyl-7-((4-(2,6-dichlorophenyl)piperidin-1-yl)methyl)-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol
- nociceptin
- Nociceptin Receptor
|
Topics |
- Animals
- Cycloheptanes
(pharmacology)
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Interleukin-1beta
(metabolism)
- Lipopolysaccharides
(toxicity)
- Mice
- Mice, Inbred BALB C
- Opioid Peptides
(metabolism, pharmacology)
- Piperidines
(pharmacology)
- Rats
- Rats, Wistar
- Receptors, Opioid
(metabolism)
- Sepsis
(chemically induced, metabolism, pathology)
- Tumor Necrosis Factor-alpha
(metabolism)
- Nociceptin Receptor
|